Pharma Foods International Co Ltd
TSE:2929
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
808
1 308
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Pharma Foods International Co Ltd
Long-Term Debt
Pharma Foods International Co Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Pharma Foods International Co Ltd
TSE:2929
|
Long-Term Debt
ÂĄ1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
111%
|
||
GNI Group Ltd
TSE:2160
|
Long-Term Debt
ÂĄ1.7B
|
CAGR 3-Years
103%
|
CAGR 5-Years
2%
|
CAGR 10-Years
19%
|
||
PeptiDream Inc
TSE:4587
|
Long-Term Debt
ÂĄ17.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Takara Bio Inc
TSE:4974
|
Long-Term Debt
ÂĄ0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
S
|
StemRIM Inc
TSE:4599
|
Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cuorips Inc
TSE:4894
|
Long-Term Debt
ÂĄ0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Pharma Foods International Co Ltd
Glance View
Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.
See Also
What is Pharma Foods International Co Ltd's Long-Term Debt?
Long-Term Debt
1.2B
JPY
Based on the financial report for Jul 31, 2024, Pharma Foods International Co Ltd's Long-Term Debt amounts to 1.2B JPY.
What is Pharma Foods International Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
111%
Over the last year, the Long-Term Debt growth was -30%. The average annual Long-Term Debt growth rates for Pharma Foods International Co Ltd have been -6% over the past three years , -10% over the past five years , and 111% over the past ten years .